This inventor holds 1 USPTO granted patent. Top assignee: Adir Et Compagnie. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of Daniel Mazeas
Introduction
Daniel Mazeas is a notable inventor based in Morancez, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with the melatoninergic system. His work is characterized by a commitment to advancing therapeutic options for various disorders.
Latest Patents
Daniel Mazeas holds a patent for "Pyridine compounds as melatonergic agents." This invention relates to a compound selected from those of formula (I), where R₁, R₂, R₃, R₄, R₅, and X are defined in the description. The medicinal product containing this compound is useful for treating disorders of the melatoninergic system. He has 1 patent to his name, showcasing his innovative approach to addressing health issues.
Career Highlights
Throughout his career, Daniel has been associated with Adir Et Compagnie, where he has contributed to various research initiatives. His expertise in medicinal chemistry has positioned him as a valuable asset in the development of new therapeutic agents. His work continues to influence the field and inspire future innovations.
Collaborations
Daniel Mazeas has collaborated with notable colleagues, including Bruno Pfeiffer and Philippe Delagrange. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
In summary, Daniel Mazeas is a distinguished inventor whose work in pyridine compounds has the potential to impact the treatment of melatoninergic disorders. His contributions to the field of medicinal chemistry are noteworthy and reflect his dedication to innovation.